Vanda Pharmaceuticals Inc. financial data

Symbol
VNDA on Nasdaq
Location
Washington, DC
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 363% % -24%
Quick Ratio 2% % 8.6%
Debt-to-equity 26% % 31%
Return On Equity -17% % -457%
Return On Assets -13% % -431%
Operating Margin -57% % -191%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59,096,630 shares 1.4%
Common Stock, Shares, Outstanding 59,095,630 shares 1.4%
Entity Public Float $319,500,000 USD -13%
Common Stock, Value, Issued $59,000 USD 1.7%
Weighted Average Number of Shares Outstanding, Basic 59,091,478 shares 1.4%
Weighted Average Number of Shares Outstanding, Diluted 59,091,478 shares 1.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $212,074,000 USD 11%
Revenue from Contract with Customer, Excluding Assessed Tax $212,074,000 USD 11%
Research and Development Expense $100,105,000 USD 27%
Costs and Expenses $333,168,000 USD 46%
Operating Income (Loss) $121,094,000 USD -223%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $107,142,000 USD -492%
Income Tax Expense (Benefit) $22,943,000 USD -1252%
Net Income (Loss) Attributable to Parent $84,199,000 USD -414%
Earnings Per Share, Basic -1 USD/shares -393%
Earnings Per Share, Diluted -1 USD/shares -393%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $70,022,000 USD -30%
Accounts Receivable, after Allowance for Credit Loss, Current $50,541,000 USD 18%
Inventory, Net $2,042,000 USD 27%
Assets, Current $367,496,000 USD -15%
Deferred Income Tax Assets, Net $103,073,000 USD 30%
Property, Plant and Equipment, Net $2,460,000 USD 13%
Operating Lease, Right-of-Use Asset $4,368,000 USD -27%
Assets $601,140,000 USD -6.8%
Employee-related Liabilities, Current $8,754,000 USD 31%
Liabilities, Current $117,870,000 USD 32%
Operating Lease, Liability, Noncurrent $3,419,000 USD -38%
Other Liabilities, Noncurrent $11,044,000 USD 19%
Liabilities $135,141,000 USD 30%
Accumulated Other Comprehensive Income (Loss), Net of Tax $540,000 USD -23%
Retained Earnings (Accumulated Deficit) $253,579,000 USD -50%
Stockholders' Equity Attributable to Parent $465,999,000 USD -14%
Liabilities and Equity $601,140,000 USD -6.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $33,147,000 USD -538%
Net Cash Provided by (Used in) Financing Activities $1,324,000 USD
Net Cash Provided by (Used in) Investing Activities $43,902,000 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 59,095,630 shares 1.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $9,480,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $70,491,000 USD -30%
Deferred Tax Assets, Valuation Allowance $8,887,000 USD 4%
Deferred Tax Assets, Gross $92,541,000 USD 7.7%
Operating Lease, Liability $7,400,000 USD -21%
Depreciation $231,000 USD 12%
Payments to Acquire Property, Plant, and Equipment $436,000 USD 6129%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $84,361,000 USD -473%
Lessee, Operating Lease, Liability, to be Paid $8,459,000 USD -24%
Property, Plant and Equipment, Gross $13,699,000 USD 3.6%
Operating Lease, Liability, Current $2,317,000 USD -5.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,409,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,792,000 USD 2.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) $7,797,000 USD -3070%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,059,000 USD -41%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,159,000 USD -10%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $18,796,000 USD 2.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,099,000 USD -49%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $7,007,000 USD 8.2%
Deferred Tax Assets, Net of Valuation Allowance $81,440,000 USD 8.6%
Share-based Payment Arrangement, Expense $10,052,000 USD -22%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%